000 01425 a2200433 4500
005 20250516123009.0
264 0 _c20130516
008 201305s 0 0 eng d
022 _a1932-6203
024 7 _a10.1371/journal.pone.0050630
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAlters, Susan E
245 0 0 _aGLP2-2G-XTEN: a pharmaceutical protein with improved serum half-life and efficacy in a rat Crohn's disease model.
_h[electronic resource]
260 _bPloS one
_c2012
300 _ae50630 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCrohn Disease
_xblood
650 0 4 _aDisease Models, Animal
650 0 4 _aFemale
650 0 4 _aGlucagon-Like Peptide 2
_xchemistry
650 0 4 _aHumans
650 0 4 _aIndomethacin
650 0 4 _aIntestine, Small
_xdrug effects
650 0 4 _aMacaca fascicularis
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aRats
650 0 4 _aRecombinant Fusion Proteins
_xchemistry
700 1 _aMcLaughlin, Bryant
700 1 _aSpink, Benjamin
700 1 _aLachinyan, Tigran
700 1 _aWang, Chia-wei
700 1 _aPodust, Vladimir
700 1 _aSchellenberger, Volker
700 1 _aStemmer, Willem P C
773 0 _tPloS one
_gvol. 7
_gno. 11
_gp. e50630
856 4 0 _uhttps://doi.org/10.1371/journal.pone.0050630
_zAvailable from publisher's website
999 _c22298964
_d22298964